Anti-ICAM-1/LFA-1 monoclonal antibody therapy prevents graft rejection and IDDM recurrence in BB rat pancreas transplantation.
Uchikoshi
F
F
First Department of Surgery, Osaka University Medical School, Japan.
Ito
T
T
Kamiike
W
W
Moriguchi
A
A
Nozaki
S
S
Ito
A
A
Kuhara
A
A
Miyata
M
M
Matsuda
H
H
Miyasaka
M
M
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000628:therapy*; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival / Q000276:immunology*; D018799:Intercellular Adhesion Molecule-1 / Q000276:immunology*; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D016169:Lymphocyte Function-Associated Antigen-1 / Q000276:immunology*; D008297:Male; D051379:Mice / Q000276:immunology; D016035:Pancreas Transplantation / Q000276:immunology*; D051381:Rats; D011913:Rats, Inbred BB; D013601:T-Lymphocytes / Q000276:immunology
D000911:Antibodies, Monoclonal; D001786:Blood Glucose; D016169:Lymphocyte Function-Associated Antigen-1; D018799:Intercellular Adhesion Molecule-1